Navigation Links
Multisol France on Track to Sell 250 Tons of International Fuel Technology, Inc. Fuel Additive Formulations
Date:2/4/2009

Multisol France realizes recurring revenue from the sale of International Fuel Technology, Inc. fuel additive formulations and is on track to sell over 250 tons of it during the first year of its distribution agreement with IFT.

St. Louis, MO (PRWEB) February 4, 2009 -- International Fuel Technology, Inc. (IFT) (OTCBB: IFUE) announced that Multisol France ("Multisol") is on track to sell over 250 tons of IFT fuel additive formulations during the first year of its distribution agreement with IFT. Multisol has been realizing recurring revenue from the sale of IFT products to: established fuel additive companies; fuel distributors; bio-diesel producers; lubricant blenders and marketers; and road transport companies.

Internaltional Fuel Technology, Inc. and Multisol signed a manufacturing, marketing and distribution agreement in July 2008. Multisol has distribution rights for IFT fuel additive formulations in France, Spain, Portugal and Belgium. Multisol is part of the Multisol Group (www.multisolgroup.com), a prominent international chemical manufacturer and distributor with operations in Europe, the Middle East and Africa.

"Since consummating our manufacturing and distribution partnerships with IFT in July of 2008, we have seen a steady increase in commercial activity related to IFT products," said Philippe Giocanti, Multisol France's Sales and Marketing Director. "We are selling IFT fuel additive formulations to numerous accounts including prominent fuel additive companies who are repackaging the formulations for resale into retail markets. The high level of end user demand and re-buy rates for these products is driving our recurring revenue streams."

"The success we are realizing is a clear indication of the end user benefits IFT products provide," said Mr. Giocanti. "We are realizing revenues from the sale of all IFT products and in particular expect sales of DiesoLIFTTM BD-3 to ramp up significantly in 2009."

DiesoLIFTTM BD-3 is IFT's proprietary fuel additive formulation for use with bio-diesel fuel blends. DiesoLIFTTM BD-3, like all IFT additive formulations, is REACH compliant. REACH (The Registration, Evaluation and Authorization of Chemicals) is the system developed by the EU (European Union) to manage the marketing and use of chemical substances in Europe.

"Our relationship with Multisol exemplifies the success of our commercial strategy of partnering with large, well-known additive and oil companies with established marketing channels and end user accounts," said Axel Farhi, IFT's Director of Global Business Development. "The added benefit of having a European option to manufacture our products is an important development for IFT as we continue to increase our commercial presence on the European continent."

About International Fuel Technology
International Fuel Technology, is a fuel performance enhancement company focused on the bulk sale of its proprietary technologies to large, industrial consumers of diesel fuel and bio-diesel fuel blends in the rail, stationary power generation and road transport industries through established industry distribution partners.

Safe Harbor Statement
Some statements contained in this release may be forward-looking within the meaning of the safe harbor clause of the Private Securities Litigation Reform Act of 1995 including, but not limited to, statements as to commercialization of the Company's products and business development activities. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that may cause the Company's actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, the Company's ability to generate revenues and other factors as described in the Company's literature and filings with the Securities and Exchange Commission.

Company Contact:
Stuart Beath
Chief Financial Officer
International Fuel Technology, Inc.
314-727-3333 x417

Further information on DiesoLIFT™ may be found at IFT's website at: www.internationalfuel.com

IFT would also like to invite you to learn more about the Company by taking a look inside their headquarters with a personal video tour. Please visit http://www.IFT-TECH.com to begin your tour today.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb1952154.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Celadrin(R) Research Unveiled at Nutrigenomics 2008 Meeting in Paris, France
3. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
4. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
5. CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
6. Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varians RapidArc(TM) Radiotherapy
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Putting stem cell research on the fast track
11. Protherics UK Ltd. Chooses TrackWise for Corrective Action and Preventive Action (CAPA) Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):